Nuzenio

For Damora Therapeutics

For Damora Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 9 latest news signals 5 publisher sources 100/100 entity strength

Latest news

Does CLARITY-101’s mutCALR Antibody Launch Change The Bull Case For Damora Therapeutics (DMRA)? - simplywall.stsimplywall.st · Mon, 10 Aug 2026 01:53:36 GMT Top Damora Therapeutics, Inc. Common Stock (DMRA) Competitors 2026 - MarketBeatMarketBeat · Sat, 08 Aug 2026 16:36:54 GMT Damora Therapeutics, Inc. Common Stock (DMRA) Stock Trends and Sentiment 2026 - MarketBeatMarketBeat · Sat, 08 Aug 2026 02:28:48 GMT Damara (DMRA): Lori Firmani plans sale of 1,800 common shares via Maxim - Stock TitanStock Titan · Thu, 06 Aug 2026 15:35:11 GMT Damora Therapeutics, Inc. Common Stock (DMRA) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeatMarketBeat · Wed, 05 Aug 2026 14:39:13 GMT Damora Therapeutics Initiates Phase 1/1b CLARITY-101 Clinical Trial of DMR-001 in Patients with Mutant Calreticulin-Driven Essential Thrombocythemia and Myelofibrosis - The Manila TimesThe Manila Times · Wed, 05 Aug 2026 12:19:47 GMT Damora Begins Testing Antibody Designed for Monthly Doses - Stock TitanStock Titan · Wed, 05 Aug 2026 12:00:00 GMT Wedbush Adjusts Damora Therapeutics Price Target to $40 From $35, Maintains Outperform Rating - Yahoo FinanceYahoo Finance · Wed, 29 Jul 2026 07:00:00 GMT

Timeline

Mon, 10 Aug 2026 01:53:36 GMTDoes CLARITY-101’s mutCALR Antibody Launch Change The Bull Case For Damora Therapeutics (DMRA)? - simplywall.st

Sat, 08 Aug 2026 16:36:54 GMTTop Damora Therapeutics, Inc. Common Stock (DMRA) Competitors 2026 - MarketBeat

Sat, 08 Aug 2026 02:28:48 GMTDamora Therapeutics, Inc. Common Stock (DMRA) Stock Trends and Sentiment 2026 - MarketBeat

Thu, 06 Aug 2026 15:35:11 GMTDamara (DMRA): Lori Firmani plans sale of 1,800 common shares via Maxim - Stock Titan

Wed, 05 Aug 2026 14:39:13 GMTDamora Therapeutics, Inc. Common Stock (DMRA) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat

Wed, 05 Aug 2026 12:19:47 GMTDamora Therapeutics Initiates Phase 1/1b CLARITY-101 Clinical Trial of DMR-001 in Patients with Mutant Calreticulin-Driven Essential Thrombocythemia and Myelofibrosis - The Manila Times

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

DMRA12 live mentions Inc6 live mentions Common Stock6 live mentions Damora Therapeutics4 live mentions MarketBeat MarketBeat3 live mentions Does CLARITY2 live mentions Antibody Launch Change2 live mentions The Bull Case2 live mentions Competitors2 live mentions Stock Trends2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for For Damora Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.